AngelHuang

Partner-in-Charge Shanghai

(T) + 86.21.2201.8000

Angel Huang, who serves as Jones Day's Shanghai Partner-in-Charge and M&A Chair for Asia, focuses her practice on cross-border M&A transactions, foreign direct investments (FDIs), private equity and venture capital transactions, and strategic investments. She has more than a decade of experience practicing in China. Angel represents clients in a broad range of sectors, including manufacturing, aviation, financial services, technology, biotech and pharmaceuticals, education, e-commerce, energy, and automotive.

Angel has extensive experience in Chinese outbound transactions where she represents both Chinese companies in their acquisitions overseas and foreign targets of Chinese outbound acquisitions. She works closely with Jones Day regulatory lawyers on the key issues involved with most Chinese outbound investments in the United States: CFIUS, export control, and antitrust. She has first-hand experience regarding current hurdles to Chinese investment in the United States and can advise clients based on her valuable local experience. In addition, she represents clients in their acquisitions of Hong Kong-listed companies and on compliance issues, working with the Firm's capital markets team in Hong Kong.

Apart from M&A work, Angel advises leading Chinese financial institutions in financing transactions, especially on mezzanine and acquisition financings in various structures.

Angel is a member of the American Bar Association and the New York State Bar Association. She is also an adjunct professor at the University of North Alabama's Executive MBA program in Suzhou and Changzhou, China, where she teaches courses on M&A and corporate governance.

Experience

  • LORD Corporation acquired by Parker Hannifin for $3.675 billionJones Day advised LORD Corporation in its $3.675 billion acquisition by Parker Hannifin Corporation.
  • PolyOne sells its Performance Products and Solutions business to SK Capital Partners for $775 millionJones Day advised PolyOne Corporation (NYSE: POL), a leading global provider of specialized polymer materials, services and solutions, in its $775 million cash sale of its Performance Products and Solutions business to SK Capital Partners.
  • Sumitomo Heavy Industries to acquire InvertekJones Day is advising Sumitomo Heavy Industries, Ltd. in the acquisition of the entire issued share capital of Invertek Drives Ltd.
  • PETRONAS Chemicals acquires Da Vinci Group B.V. for €163 million (US$182.2 million)Jones Day advised PETRONAS Chemicals Group Berhad (PCG) in its acquisition of a 100 percent stake in Da Vinci Group B.V. from its shareholders including funds managed by Bencis Capital Partners for €163 million (US$182.2 million).
  • Western Digital acquires Kazan NetworksJones Day advised Western Digital Corporation (NASDAQ:WDC) in its acquisition of Kazan Networks Corp., a provider of industry leading NVMe™-over-Fabric (NVMe-oF) ASIC and adapter products for next-generation data center architectures.
  • CIRCOR sells Pibiviesse S.p.A. to CERTINAJones Day advised CIRCOR International, Inc. in the sale of its Italian long-cycle upstream oil and gas engineered valve business (Pibiviesse S.p.A.) to P&P Flow Control, an affiliate of Certina Holding AG.
  • AURELIUS to sell Solidus Solutions for €330 million (US$375.6 million)Jones Day is advising AURELIUS Equity Opportunities SE & Co. KGaA on the full shop auction sale of the Solidus Solutions group to funds advised by Centerbridge Partners, L.P.
  • Chroma acquires 20.5 percent of CamtekJones Day advised Chroma ATE Inc., a leading Taiwanese corporation, in its acquisition of approximately 20.5 percent of the shares of Camtek Ltd. at $9.50 per share.
  • Huadong Medicine invests in R2 Dermatology and enters into distribution agreementJones Day advised Huadong Medicine Co. Ltd., a Chinese manufacturer and distributor of pharmaceutical and other medical products, in connection with its subscription of Series B Preferred Shares of R2 Dermatology, Inc., and the negotiation of a distribution agreement authorizing Huadong Medicine as an exclusive distributor in Asia for R2's skin whitening products.
  • NVIDIA to acquire Mellanox Technologies for $6.9 billionJones Day is advising NVIDIA Corporation in its acquisition of Mellanox Technologies, Ltd., an Israel-based leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage.
  • INVISTA sells Apparel & Advanced Textiles business to Shandong Ruyi Investment HoldingJones Day advised INVISTA, a subsidiary of Koch Industries, Inc., in its sale of INVISTA’s Apparel & Advanced Textiles business to Shandong Ruyi Investment Holding.
  • PolyOne acquires Fiber-Line for $120 millionJones Day advised PolyOne Corporation, a premier global provider of specialized polymer materials, services, and solutions, in its $120 million acquisition of Fiber-Line, a global leader in customized engineered fibers and composite materials.
  • Molex acquires Laird Connected Vehicle Solutions divisionJones Day advised Molex Electronic Technologies, LLC, a leading global manufacturer of electronic solutions, on its acquisition of the Connected Vehicle Solutions division of Laird Limited.
  • Huadong Medicine announces £169 million (US$222 million) takeover offer for and acquisition of Sinclair Pharma PlcJones Day advised Huadong Medicine Co. Ltd. ("HMC") and its subsidiary, Huadong Medicine Aesthetics Investment (HongKong) Limited ("Huadong"), on Huadong's takeover offer for and acquisition of Sinclair Pharma Plc with a total value of approximately £169 million (US$222 million).
  • Timken acquires Cone DriveJones Day advised The Timken Company in its acquisition of Cone Drive, a leader in precision drives used in diverse markets including solar, automation, aerial platforms, and food and beverage.
  • Arsenal Capital Partners sells IGM Resins to AstorgJones Day advised Arsenal Capital Partners (“ACP”) on the full shop auction of IGM Resins Cooperative U.A. and its group (“IGM”) to European private equity firm Astorg as the successful bidder.
  • Sequoia China invests in HiFiBiO TherapeuticsJones Day represented Sequoia China in connection with its purchase of Series B Convertible Preferred Stock in a private placement by HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-B-cell screening and analysis.
  • PAG invests in Key Safety Systems to finance acquisition of global assets of Takata CorporationJones Day represented PAG Asia Capital Ltd. and PAG Asia II LP in connection with its investment in Key Safety Systems, a subsidiary of China-based Ningbo Joyson Electronic Corporation, to finance the acquisition of substantially all of the global assets of Takata Corporation out of bankruptcy in the U.S. and Japan and certain non-bankruptcy transactions elsewhere in the world.
  • Cardinal Health sells its Cardinal Health China distribution business to Shanghai Pharmaceuticals for $1.2 billionJones Day advised Cardinal Health in the $1.2 billion sale of its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co., Ltd.
  • Shenzhen Energy Group acquires PV solar generation facilities from Recurrent Energy for $232 millionJones Day advised Shenzhen Energy Group Co., Ltd. on its $232 million acquisition of a portfolio of PV solar generation facilities in California from Recurrent Energy, a wholly owned U.S. subsidiary of Canadian Solar.
  • Speaking Engagements

    • January 26, 2016
      CLE Academy Shanghai 2016
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.